BAJAJ BROKING

Notification
No new Notification messages
PDP Shipping & Projects IPO is Open!
Apply for the PDP Shipping & Projects IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Syngene International to Invest $56 Million in US Subsidiary Expansion

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Syngene International plans an additional investment of $56 million in Syngene USA Inc., acquiring a facility for $36.5 million. The acquisition will expand its presence in human and animal health markets. Syngene International share price closed at Rs 678 on BSE on Monday.

 

Syngene International has announced an additional investment of up to $56 million in its wholly-owned US subsidiary, Syngene USA Inc. The move includes acquiring a facility from Emergent Manufacturing Operations Baltimore, LLC for $36.5 million, with the remaining funds allocated for making the facility operational. This expansion aims to enhance its capabilities in serving both human and animal health market segments. The transaction is expected to close by March 2025, subject to regulatory approvals.

Also read: Bharat Electronics Secures ₹843 Crore in New Defence Orders

Key takeaways

  • Investment amount: Syngene International to invest $56 million in Syngene USA Inc.

  • Facility acquisition: Acquiring the Baltimore-based facility for $36.5 million.

  • Operational costs: An estimated $50 million will be spent on facility setup, including acquisition and expenses.

  • Market expansion: Strengthening presence in human and animal health sectors.

  • Syngene International share price: Closed at Rs 678 on BSE, down 0.22% on Monday.

Also read: Aditya Birla Capital Infuses ₹300 Crore into Housing Finance Subsidiary via Rights Issue

Financial breakdown of the investment

Syngene International’s investment includes both the acquisition cost and expenses for making the facility fully operational. The move aligns with the company’s strategy of expanding its US footprint to meet growing market demands.

Investment category

Amount (in USD)

Facility acquisition

$36.5 million

Operational expenses

$19.5 million

Total investment

$56 million

Strategic expansion in the US market

The acquisition of the Baltimore facility is part of Syngene International’s long-term strategy to expand its contract research, development, and manufacturing services in the US. The facility will cater to both pharmaceutical and biotechnology clients, improving the company’s ability to serve international markets efficiently.

With this move, Syngene International aims to strengthen its contract development and manufacturing organisation business, which has been a key growth driver. The additional investment will help the company enhance its infrastructure and meet rising demand from the human and animal health segments.

Syngene International’s decision to invest $56 million in its US subsidiary reflects its commitment to expanding global operations. The acquisition of the Baltimore facility will enhance its research and manufacturing capabilities, positioning it as a stronger player in the market. Investors will be closely monitoring Syngene International share price, as the investment is expected to drive future growth and strengthen its global presence.

Also read: Sun Pharma to Acquire Checkpoint Therapeutics for $355 Million

Do you have a trading account app or demat account app?

You can open an account with Bajaj Broking in minutes.

Download the Bajaj Broking app now from Play Store or App Store.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 lakh+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text